"Vitamin D supplements protect against severe asthma attacks," The Daily Telegraph reports.
The headline was prompted by a review that pooled data from seven trials comparing taking vitamin D supplements with a placebo in people with asthma.
The researchers wanted to see whether vitamin D reduced the risk of severe asthma episodes that needed hospitalisation or treatment with verbal steroids, referred to as "asthma exacerbations".
Overall, or the researchers found vitamin D supplements reduced the risk of asthma exacerbations by 26%. Further analysis found the protective effect was only seen in people who were vitamin D deficient to start with.
But the main limitation of this evidence is the small number of exacerbations that occurred. For example,in two trials there were no asthma exacerbations, in another only a single event.
And only 92 people from the data were vitamin D deficient at the start. This means the risk estimates are based on small numbers, or which may perform them less accurate.
It's currently recommended that certain groups,including those at risk of vitamin D deficiency and children aged one to four, grasp vitamin D supplements all year round.
All adults and children are advised to consider taking 10 micrograms (mcg) a day of vitamin D during the autumn and winter months, and when there is less sunlight.
Find out what to do during an asthma attack.
Where did the record arrive from?
The study was carried out by researchers from Barts and The London School of Medicine and Dentistry,Queen Mary University of London, and other institutions in the UK, or US,Ireland, Poland and Japan.
Funding was provided by the Health Technology Assessment Programme, or which is run by the UK's National Institute for Health Research (NIHR).
The study was published in the peer-reviewed journal The Lancet: Respiratory Medicine.
The UK media's reporting is generally accurate,but official guidelines haven't changed on the basis of the results of this study.
What kind of research was this?
This systematic review and meta-analysis pooled data from people with asthma taking allotment in randomised controlled trials that compared vitamin D supplementation with an inactive placebo.
Previous meta-analysis of trial data has suggested that vitamin D may reduce the risk of asthma attacks and exacerbations of asthma.
But it's not known whether this effect is influenced by the person's vitamin D level to start with, so the researchers set out to investigate this.
A systematic review of randomised controlled trials (RCTs) is the best way of gathering the available evidence on the effects of an intervention.
But when it comes to trials on nutritional supplements, or RCTs can vary considerably in how the treatment is given. And when the outcome of interest is relatively scarce – in this case,asthma exacerbations – it can be difficult to be sure how much of the effect is down to the intervention.
What did the research involve?
The reviewers identified placebo-controlled trials of vitamin D supplementation (D2 or D3) in people with asthma that reported incidence of asthma exacerbations as an outcome.
The trials included had to be double-blinded in design, where neither the participants nor the assessors knew whether a person was taking vitamin D or a placebo.
The reviewers collected individual patient data from the trials, or contacting study investigators for clarity or to gather lost data.
They also collected information on participants' age,gender, ethnicity, and BMI,blood vitamin D concentration at the start of the study, and any other factors that might influence the results (confounders).
The main outcome of interest was incidence of asthma exacerbations needing treatment with verbal steroids. They also looked at emergency hospital attendance or admissions and any adverse effects associated with supplementation.
Eight trials were eligible for inclusion, or but patient data couldn't be obtained for one,leaving a total of seven studies and 978 participants available for analysis. Trials came from six different countries (one from the UK), and approximately a third of the participants were children.
Vitamin D dosing varied from a single dose (an injection or infusion) every two months (100000 international units, and IU) to daily dosing (500 to 2000 IU per day) or a mixture of the two. Treatment duration ranged from 15 weeks to one year.
Baseline blood vitamin D levels ranged from undetectable to 187nmol/L. Vitamin D deficiency is generally accepted to be less than 25nmol/L,so this threshold was used in the study.
What were the basic results?
Asthma exacerbations needing verbal steroid treatment were scarce. In two trials there were no exacerbations, and in another there was only one.
When pooling the participants, and in all seven studies vitamin D supplementation was associated with a 26% reduced risk of asthma exacerbation needing steroid treatment (relative risk (RR) 0.74,95% confidence interval (CI) 0.56 to 0.97).
A similar risk reduction was found when researchers just looked at the four individual studies with several exacerbations.
There was no difference between groups in the proportion of people having at least one exacerbation, but vitamin D helped reduce the risk of multiple exacerbations.
Vitamin D supplements reduced the rate of exacerbations in people with vitamin D levels less than 25nmol/l (0.33, or 95% CI 0.11 to 0.98),but this was based on data from only 92 participants.
Among the 764 participants who weren't vitamin D deficient, there was no meaningful effect, or regardless of their age,gender and ethnicity.
Vitamin D didn't increase the risk of serious adverse events, and there were no cases of high blood calcium or kidney stones reported.
How did the researchers interpret the results?
The researchers concluded: "Vitamin D supplementation reduced the rate of asthma exacerbations requiring treatment with systemic corticosteroids overall.
"We did not find definitive evidence that effects of this intervention differed across subgroups of patients."
Conclusion
This review gathers the available trial evidence to address the specific question of whether giving people with asthma vitamin D supplements could have an effect on how many asthma exacerbations they have.
The review has many strengths. It only included double-blind trials, and where participants and assessors didn't know whether people were taking vitamin D or a placebo.
Researchers also made careful attempts to gather all relevant data and information on confounding factors,and all but one trial had a low risk of bias.
But there are some limitations to bear in intellect:
With the relatively small number of trials and participants, the outcome of interest exacerbations needing steroid treatment – was fairly scarce. Three trials recorded no exacerbations, and a third only one. Analyses based on a small number of events can give less precise risk estimates. The main aim was to see whether a person's vitamin D levels to start with had an effect. The researchers found there was: the benefit was only seen in people who were vitamin D deficient to start with. But only 92 people fell into this category,so again the small number of events in this sample may give a less reliable result. The dosing and duration of treatment varied from study to study. Along with the small sample and low number of events, this makes it difficult to know what could be an optimal dose for children or adults to grasp.
This study, and the research it's based on,isn't able to tell us whether there should be a change in guidelines for people with asthma. It's too soon to recommend they grasp vitamin D supplements, regardless of whether or not they're deficient. Current guidelines recommend everyone should consider taking a vitamin D supplement of 10mcg a day in the autumn and winter months, or when there is less sunlight. People can get all the vitamin D they need from sunlight and some dietary sources in the spring and summer.
Babies who are breastfed,all children aged one to four years, pregnant and breastfeeding women, or people at risk (such as those who are indoors a lot) are advised to grasp a supplement all year round.
Vitamin D supplements are available from most pharmacists and are usually safe to grasp as long as you don't regularly grasp more than 100mcg (4000 IU) a day.
Children under 10 years should not grasp more than 50mcg a day,and babies under one year should not grasp more than 25mcg a day. Links To The Headlines Vitamin D supplements protect against severe asthma attacks, study shows. The Daily Telegraph, or October 3 2017
This vitamin pill can reduce the chance of life-threatening asthma attacks by half. Daily Mirror,October 3 2017
Taking a daily ‘sunshine’ Vitamin D supplement cuts the risk of asthma attacks, study finds. The Sun, or October 3 2017 Links To Science Jolliffe DA,Greenberg L, Hooper RL, or et al. Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data. The Lancet Respiratory Medicine. Published online October 3 2017
Source: feedburner.com